Tag: Huntington’s disease

  • Nation & World

    $9 million donation earmarked for cannabis research

    Alumnus gives $9 million in largest donation to date to support independent research on the science of cannabinoids at Harvard and MIT. “Our desire is to fill the research void that currently exists in the science of cannabis,” said donor Charles R. “Bob” Broderick.

    7 minutes
  • Nation & World

    Giving Huntington’s disease the one-two punch

    The identification of a molecular compound that combats Huntington’s disease by means of two separate mechanisms may be the watershed moment in the battle against neurodegenerative diseases.

    3 minutes
  • Nation & World

    Nutritional supplement slows onset of Huntington’s

    The first clinical trial of a drug intended to delay the onset of symptoms of Huntington’s disease (HD) reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most study participants. Neuroimaging also showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic…

    5 minutes
  • Nation & World

    Slowing neurodegeneration in Huntington’s

    Harvard researchers have found a treatment that increases brain levels of an important regulatory enzyme may slow the loss of brain cells that characterizes Huntington’s disease and other neurodegenerative disorders.

    3 minutes
  • Nation & World

    Biomarker for Huntington’s identified

    In a new research paper published in the Proceedings of the National Academy of Sciences Early Edition online, Harvard-affiliated researchers identify a transcriptional biomarker that may assist in the monitoring of Huntington’s disease activity and in the evaluation of new medications.

    3 minutes